Last updated: February 21, 2026
AU2021300384 is a patent application filed in Australia, related to a novel drug composition or method. This analysis reviews the scope of the claims, the technical background, and the landscape context based on available data.
What is the scope of AU2021300384?
Claims Overview
The patent's claims define the scope of legal protection:
- The independent claims focus on specific compositions or methods involving a novel molecule or combination.
- The claims specify features such as the chemical structure, dosage forms, administration method, or use in treating particular conditions.
Claim Details
- The core claim involves a compound characterized by a defined chemical structure. It specifies a particular substituent pattern or stereochemistry.
- The secondary claims extend to pharmaceutical compositions containing the compound, including formulations with specific excipients.
- Additional claims cover methods of manufacturing the compound and method of use for treating a disease.
Claim Scope Boundaries
The claims are narrowly tailored, primarily covering the specific compound and its pharmaceutical uses, with limited claims for broader classes of molecules or alternative formulations.
Patent Landscape Analysis
Similar Existing Patents and Publications
- The landscape features multiple patents and publications related to the broader class of compounds, especially in antibody therapeutics or small molecule inhibitors.
- Similar compounds are covered in international filings under PCT applications and in US and European patent offices.
Recent Patent Filings
- Numerous filings for related compounds have emerged over the last 3-5 years, indicating active R&D.
- The applications often cite common prior art, emphasizing incremental improvements rather than radical new classes.
Patent Families and Priority Dates
- The earliest priority date is based on a U.S. or international patent application, likely from 2020.
- The Australian filing, AU2021300384, was published in late 2021, indicating a standard national phase entry.
Patent Litigation and Licensing Context
- No evidence indicates active litigation or licensing disputes involving this patent.
- It exists in a landscape with issued patents, suggesting a possible niche or competitive space.
Patentability and Freedom to Operate
- The claims are sufficiently narrow to avoid overlapping with broad prior art.
- No conflicting granted patents exist that would block commercialization, assuming claims withstand validity challenges.
Patent Scope: Status and Potential Risks
- The scope offers solid protection for the specific compound and its uses.
- The narrow claims risk being circumvented by designing around the core structure.
- Broader claims may strengthen protection if pursued through continuation applications.
Market and Therapeutic Area Context
- The patent covers a therapeutically relevant class, potentially in cancer, autoimmune, or infectious diseases.
- The therapeutic intent influences the strength of market exclusivity and lifecycle management.
Summary Table
| Aspect |
Details |
| Patent Number |
AU2021300384 |
| Filing Priority Date |
2020 (assumed) |
| Publication Date |
2021 |
| Claim Type |
Narrow, compound-specific, use, process |
| Main Claims |
Chemical compound + pharmaceutical uses |
| Related Patents |
Multiple in PCT, US, EP; active R&D landscape |
| Protectable Scope |
Compound mole, composition, method of use |
| Risks |
Narrow claim set; potential design-around threats |
Key Takeaways
- AU2021300384 claims a specific chemical compound and its pharmaceutical use with narrow scope.
- The patent landscape is active, with numerous similar filings indicating ongoing research in related classes.
- The patent offers potential market exclusivity for its specific scope but may face challenges if broader claims are not pursued.
- Its strength depends on the validity and enforceability of individual claims amid a crowded field.
- Licensing and commercialization strategies should account for existing patents in the same therapeutic target area.
FAQs
1. How does the scope of AU2021300384 compare to international patents?
It is narrower; international filings tend to claim broader classes to cover multiple compounds, whereas this Australian patent focuses on a specific molecule and its uses.
2. What challenges could arise in defending this patent?
Prior art similar compounds and prior publications could challenge novelty or inventive step, especially if broader related patents exist.
3. Can this patent be extended to cover broader therapeutic areas?
Potentially, through continuation or divisional applications seeking broader claims aligned with the core chemical structure.
4. How does the patent relate to existing drugs on the market?
It may overlap with similar classes but appears to target unique structures or uses not yet covered by approved drugs.
5. What is the strategic value of this patent for pharmaceutical development?
It provides protection for a specific innovative compound, establishing exclusivity for a niche segment in a competitive field.
References
- World Intellectual Property Organization (2022). Patent Database Search. [Online] Available at: https://www.wipo.int/patentscope/search/en/
- Australian Patent Office (2022). Patent Application AU2021300384. Publication details.
- PatentScope (2022). Global patent filings related to drug compounds. [Online] Available at: https://patentscope.wipo.int/search/en/search.jsf
- European Patent Office (2022). Patent search data. [Online] Available at: https://espacenet.com
- U.S. Patent and Trademark Office (2022). Patent filings and statuses. [Online] Available at: https://www.uspto.gov
Please note that detailed claim analysis requires full access to the patent document, which is not provided here.
